Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology | Rheumatology | Family Medicine
Disease Category: Psoriasis and Psoriatic Disorders
Location: United States, CA
A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis
Patient Inclusion Criteria:
Patient Exclusion Criteria:
CW ID: 169613
Date Last Changed:
July 23, 2013
Dermatology Specialists, Inc.3629 Vista WayOceanside, CA 92056Phone: 760-757-7546
Dermatology Specialists, Inc.
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.